1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Asthma Drugs Market – By Medication

1.3.2        Europe Asthma Drugs Market – By Route of Administration

1.3.3        Europe Asthma Drugs Market – By Distribution Channel

1.3.4        Europe Asthma Drugs Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Asthma Drugs Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Europe – PEST Analysis

4.3         Expert Opinion

5.           Asthma Drugs Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Environmental Implications & Genetic Implications of Air Pollution

5.1.2        Growing Prevalence of Physiological Disorders Harboring Asthma

5.2         Market Restraints

5.2.1        Unmet Medical Needs

5.3         Market Opportunities

5.3.1        Opportunities with Commercialization of Biologics

5.4         Future Trends

5.4.1        Increasing Research Activities and Product Innovations

5.5         Impact Analysis

6.           Asthma Drugs Market– Europe Analysis

6.1         Europe Asthma Drugs Market Revenue Forecast and Analysis

7.           Asthma Drugs Market Analysis – by Medication

7.1         Overview

7.2         Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)

7.3         Quick Relief Medications

7.3.1        Overview

7.3.2        Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Long-term Control Medications

7.4.1        Overview

7.4.2        Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asthma Drugs Market Analysis – By Route of Administration

8.1         Overview

8.2         Asthma Drugs Market Revenue Share, By Route of Administration (2021 and 2028)

8.3         Inhaled

8.3.1        Overview

8.3.2        Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

8.4         Prefilled Syringe/Vials

8.4.1        Overview

8.4.2        Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

8.5         Others (Oral, Nasal, Ophthalmic Etc.)

8.5.1        Overview

8.5.2        Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.           Asthma Drugs Market Analysis – By Distribution Channel

9.1         Overview

9.2         Asthma Drugs Market Revenue Share, By Distribution Channel (2021 and 2028)

9.3         Online Pharmacies

9.3.1        Overview

9.3.2        Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.4         Hospital Pharmacies

9.4.1        Overview

9.4.2        Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

9.5         Retail Pharmacies and Drugstores

9.5.1        Overview

9.5.2        Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

10.        Asthma Drugs Market – Europe Analysis

10.1      Europe

10.1.1     Overview

10.1.2     Europe: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.3     Europe: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.4     Europe: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.5     Europe: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6     Europe: Asthma Drugs Market, by Country, 2021 & 2028 (%)

10.1.6.1       Germany: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.1       Germany: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.1.2       Germany: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.1.3       Germany: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.1.4       Germany: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6.2       UK: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.1       UK: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.2.2       UK: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.2.3       UK: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.2.4       UK: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6.3       France: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.1       France: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.3.2       France: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.3.3       France: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.3.4       France: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6.4       Italy: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.4.1       Italy: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.4.2       Italy: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.4.3       Italy: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.4.4       Italy: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6.5       Spain: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.5.1       Spain: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.5.2       Spain: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.5.3       Spain: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.5.4       Spain: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6.6       Rest of Europe: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.6.1       Rest of Europe: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

10.1.6.6.2       Rest of Europe: Asthma Drugs Market, by Medication, 2019–2028 (USD Million)

10.1.6.6.3       Rest of Europe: Asthma Drugs Market, by Route of Administration, 2019–2028 (USD Million)

10.1.6.6.4       Rest of Europe: Asthma Drugs Market, by Distribution Channel, 2019–2028 (USD Million)

11.        Asthma Drugs Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      AstraZeneca

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      TEVA PHARMACEUTICAL INDUSTRIES LTD

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      GlaxoSmithKline plc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Boehringer Ingelheim International GmbH

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Merck & Co., Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Koninklijke Philips N.V.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Sanofi

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Pfizer Inc. (Arena Pharmaceutical GmbH)

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Novartis AG

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Abbott

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Odds Ratio (OR) For Mental Disorders among Adults with Asthma Vs Without Asthma

Table 2.             Asthma Death Rates for Select Countries, 2018

Table 3.             Common SABAs

Table 4.             Commonly inhaled corticosteroids

Table 5.             Europe: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 6.             Europe: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 7.             Europe: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 8.             Germany: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 9.             Germany: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 10.          Germany: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11.          UK: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 12.          UK: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 13.          UK: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 14.          France: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 15.          France: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 16.          France: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 17.          Italy: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 18.          Italy: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 19.          Italy: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 20.          Spain: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 21.          Spain: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 22.          Spain: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of Europe: Asthma Drugs Market, by Medication – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of Europe: Asthma Drugs Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 25.          Rest of Europe: Asthma Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 26.          Organic Developments in the Asthma Drugs Market

Table 27.          Inorganic Developments in the Asthma Drugs Market

Table 28.          Glossary of Terms, Asthma Drugs Market

LIST OF FIGURES

Figure 1.           Asthma Drugs Market Segmentation

Figure 2.           Asthma Drugs Market, By Country

Figure 3.           Europe Asthma Drugs Market Overview

Figure 4.           The Long Term Control Medications Segment Held Largest Share of Mode of Service in the Asthma Drugs Market

Figure 5.           EuropeAsthma Drugs Market- Leading Country Markets (US$ Million)

Figure 6.           Europe PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           Impact of Low Mood/Anxiety on Asthma

Figure 9.           Asthma Drugs Market Impact Analysis of Drivers and Restraints

Figure 10.        Europe Asthma Drugs Market– Revenue Forecast and Analysis – 2020- 2028

Figure 11.        Asthma Drugs Market Revenue Share, by Medication (2021 and 2028)

Figure 12.        Quick Relief Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Long-term Control Medications: Asthma Drugs Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Asthma Drugs Market Share, By Route of Administration, 2021 and 2028 (%)

Figure 15.        Inhaled: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 16.        Prefilled Syringe/Vials: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 17.        Others: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 18.        Asthma Drugs Market Share, By Distribution Channel, 2021 and 2028 (%)

Figure 19.        Online Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 20.        Hospital Pharmacies: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 21.        Retail Pharmacies and Drugstores: Asthma Drugs Market– Revenue and Forecast to 2028 (USD Million)

Figure 22.        Europe: Asthma Drugs Market, by Key Country – Revenue (2021) (USD Million)

Figure 23.        Europe: Asthma Drugs Market Revenue and Forecast to 2028 (USD Million)

Figure 24.        Europe: Asthma Drugs Market, by Country, 2021 & 2028 (%)

Figure 25.        Germany: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        UK: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        France: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Italy: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Spain: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Rest of Europe: Asthma Drugs Market – Revenue and Forecast to 2028 (USD Million)